KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Income towards Parent Company: 2011-2025

Historic Income towards Parent Company for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Sep 2025 value amounting to -$45.1 million.

  • Supernus Pharmaceuticals' Income towards Parent Company fell 217.20% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.1 million, marking a year-over-year decrease of 131.95%. This contributed to the annual value of $73.9 million for FY2024, which is 5512.84% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Income towards Parent Company stood at -$45.1 million, which was down 300.53% from $22.5 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Income towards Parent Company ranged from a high of $38.5 million in Q3 2024 and a low of -$45.1 million during Q3 2025.
  • For the 3-year period, Supernus Pharmaceuticals' Income towards Parent Company averaged around $3.7 million, with its median value being $1.2 million (2023).
  • In the last 5 years, Supernus Pharmaceuticals' Income towards Parent Company surged by 2,506.53% in 2024 and then slumped by 9,641.13% in 2025.
  • Supernus Pharmaceuticals' Income towards Parent Company (Quarterly) stood at $2.4 million in 2021, then skyrocketed by 943.45% to $25.5 million in 2022, then tumbled by 95.39% to $1.2 million in 2023, then soared by 1,208.68% to $15.4 million in 2024, then plummeted by 217.20% to -$45.1 million in 2025.
  • Its Income towards Parent Company was -$45.1 million in Q3 2025, compared to $22.5 million in Q2 2025 and -$11.8 million in Q1 2025.